References
General References:|1. Nelson, JM.; Chiller, TM.; Powers, JH.; Angulo, FJ. (Apr 2007). "Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story.". Clin Infect Dis 44 (7): 977–80. doi:10.1086/512369. PMID 17342653.|2. Padeĭskaia, EN. (2003). "[Norfloxacin: more than 20 years of clinical use, the results and place among fluoroquinolones in modern chemotherapy for infections]". Antibiot Khimioter 48 (9): 28–36. PMID 15002177.|3. Rafalsky, V.; Andreeva, I.; Rjabkova, E.; Rafalsky, Vladimir V (2006). "Quinolones for uncomplicated acute cystitis in women.". Cochrane Database Syst Rev 3: CD003597. doi:10.1002/14651858.CD003597.pub2. PMID 16856014.|4. "HQ 545710". faqs.org. 30 October 1998.|5. Merck Sharp & Dohme (September 2008). "TABLETS NOROXIN® (NORFLOXACIN)" (PDF). USA: FDA.|6. "EMEA Restricts Use of Oral Norfloxacin Drugs in UTIs". UK: DGNews. 24 July 2008.|7. Merck Sharp & Dohme (September 2000). "Chibroxin (Norfloxacin) Ophthalmic solution" (PDF). USA: FDA.|8. "Showing drug card for Norfloxacin (DB01059)". Canada: DrugBank.ca. 19 February.|9. http://sciencelinks.jp/j-east/article/200109/000020010901A0173889.php|USBio References
No references available